• 中国精品科技期刊
  • 中国高校百佳科技期刊
  • 中国中文核心期刊
  • 中国科学引文数据库核心期刊
Advanced Search
LIN Xu-sheng, JIANG Hai-song, Jian-ping. In situ intestinal absorption kinetics of valsartan in rats[J]. Journal of China Pharmaceutical University, 2012, 43(2): 130-136.
Citation: LIN Xu-sheng, JIANG Hai-song, Jian-ping. In situ intestinal absorption kinetics of valsartan in rats[J]. Journal of China Pharmaceutical University, 2012, 43(2): 130-136.

In situ intestinal absorption kinetics of valsartan in rats

More Information
  • The aim of this study was to investigate the absorption mechanism of valsartan in various intestinal segments. Single-pass intestinal perfusion (SPIP) model was used to study the intestinal absorption kinetics of valsartan and the effects of drug transporters,including P-glycoprotein (P-gp) and organic anion transporting polypeptide (OATP),on in situintestinal absorption at different segments in rats.Valsartan was assayed by RP-HPLC. Valsartan was absorbed in the whole intestine,and its absorption rate of valsartan was influenced by the pH of the perfusion solution and intestinal segments. The absorption rate was descended as the order of duodenum,jejunum,colon and ileum. Valsartan absorption can be described best by nonlinear dynamic absorption parameters (Ka=0.328 h-1;Vm=72.652 μmol/(L·h);Km=10.968 μmol/L;Vms=69.115 μmol/(L·h);Kms=0 μmol/L).The absorption rate constants (Ka) in jejunum,colon and ileum were estimated to be (0.595±0.091),(0.586±0.153) and (0.551±0.030) h-1,respectively.Group containing P-gp inhibitor had marked increased of Papp,while for OATP inhibitor, Papp was significantly decreased (P<0.05).In conclusion,the intestinal absorption mechanism of valsartan was demonstrated to be the combination of active transport and passive diffusion,according with the nonlinear kinetics.
  • Related Articles

    [1]Studies on Pharmacokinetics and Relative Bioavailability of Aceclofenac Controlled-Release Tablets in Dogs[J]. Journal of China Pharmaceutical University, 2004, (5): 57-59.
    [2]Relative Bioavailability and Pharmacokinetics of Roxithromycin Dispersive Tablets in Healthy Volunteers[J]. Journal of China Pharmaceutical University, 2004, (4): 41-43.
    [3]Pharmacokinetics and Bioavailability of Cinnamic Acid in Mice[J]. Journal of China Pharmaceutical University, 2004, (4): 38-40.
    [4]Preparation of Sodium Valproate Sustained-Release Tablets and Evaluation on its Bioavailability in Healthy Volunteers[J]. Journal of China Pharmaceutical University, 2000, (6): 22-25.
    [5]Pharmacokinetics and Relative Bioavailability of Gliquidone Capsules and Tablets[J]. Journal of China Pharmaceutical University, 2000, (6): 19-21.
    [6]Pharmacokinetics andRelative Bioavailability of Sustained-release Felodipine Capsule in Healthy Volunteers[J]. Journal of China Pharmaceutical University, 2000, (3): 26-29.
    [7]Preparation of Naproxen Sustained Release Tablets and Evaluation on its Bioavailability in Healthy Human Volunteers[J]. Journal of China Pharmaceutical University, 1999, (2): 12-15.
    [8]Study on Pharmacokinetics and Relative Bioavailability of Cefaclor Sustained Release Tablets in 8 Chinese Healthy Subjects[J]. Journal of China Pharmaceutical University, 1998, (5): 29-32.
    [9]Pharmacokinetics and Relative Bioavailability of Cyclosporin Pearls in Healthy Volunteers[J]. Journal of China Pharmaceutical University, 1996, (6): 20-22.
    [10]Pharmacokinetics and Relative Bioavailability of Tamoxifen in Healthy Volunteers[J]. Journal of China Pharmaceutical University, 1995, (2): 84-86.

Catalog

    Article views (1930) PDF downloads (2758) Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return